-
Janney: Amicus Therapeutics Has Significant Upside From Gene Therapy Pipeline
Friday, April 5, 2019 - 12:27pm | 379Amicus Therapeutics, Inc. (NASDAQ: FOLD) has an extensive portfolio of novel therapies for rare diseases with a focus on lysosomal storage disorders, according to Janney Montgomery Scott. The Analyst Janney's Yun Zhong initiated coverage of Amicus Therapeutics with a Buy rating and $...
-
American Water Works No Longer A Buy, Janney's Gaugler Cuts On 'Concern' With Valuation
Friday, February 26, 2016 - 11:55am | 265Janney Montgomery Scott's Michael Gaugler downgraded the rating on American Water Works Company Inc (NYSE: AWK) from Buy to Neutral, given that the stock is now trading above the fair value estimate of $66. "The shares have performed well in recent years, riding a wave of higher...
-
Janney's Gaugler Downgrades Sunedison On HECO Termination, Warns Cash Outlook Might Not Be Met
Friday, February 19, 2016 - 11:05am | 308Janney's Michael Gaugler has downgraded the rating on Sunedison Inc (NYSE: SUNE) from Buy to Neutral, while lowering the price target to $5.50. The downgrade is based on the recent announcement by Hawaiian Electric Industries, Inc. (NYSE: HE) of the withdrawal of its power purchase agreement with...
-
Janney Initiates CareDx With Buy Rating, $12 Target
Wednesday, February 10, 2016 - 11:24am | 175Janney Montgomery Scott’s Paul Knight has initiated coverage of CareDx Inc (NASDAQ: CDNA) with a Buy rating and fair value estimate of $12. Unlike most of its peers, Knight believes that CareDx has meaningfully greater upside potential. The company is a leader in the heart transplant...
-
Janney Analyst Starts Clovis Oncology At Buy, Expects Regulatory Approvals Coming In 2016
Thursday, December 17, 2015 - 10:51am | 292The share price of Clovis Oncology Inc (NASDAQ: CLVS) has appreciated 7.57 percent in the last month, after having fallen 70.08 percent over the past three months. Janney’s Roy Buchanan has initiated coverage of the company with a Buy rating and fair value of $50. Buchanan expects...
-
World Acceptance May Face Legal Action; Janney's John Rowan Thinks It's No Longer A Buy
Tuesday, August 11, 2015 - 9:15am | 265In a report published Tuesday, Janney Montgomery Scott analyst John Rowan downgraded the rating on World Acceptance Corp. (NASDAQ: WRLD) from Buy to Neutral, with a fair value estimate of $38. Analyst John Rowan mentioned that World Acceptance had received a Notice and Opportunity to Respond and...
-
IPO Outlook for Friday, April 11: City Office, Paycom Software, Farmland Partners & More
Friday, April 11, 2014 - 7:45am | 748Ally Financial (NYSE: ALLY), Cerulean Pharma (NASDAQ: CERU), and Adamas Pharmaceuticals (NASDAQ: ADMS) opened for trading Thursday amid a stock market in free-fall. Ally Financial, formerly known as GMAC, began trading 95M shares as the US Treasury divests itself of 177M shares. The stock...
-
Janney Upgrades International Game Technology from Neutral to Buy
Wednesday, August 10, 2011 - 7:44am -
A Peek Into The Market Before The Trading Starts
Thursday, June 2, 2011 - 7:25am | 394Pre-open movers US stock futures are higher this morning, as investors are awaiting data on jobless claims and sales data from retailers. Futures on the Dow Jones Industrial Average gained 32 points to 12,306.00 and futures on the S&P 500 stock index rose 4.10 points to 1,316.20. Nasdaq 100...
-
Peet's Coffee Not Yet Commenting On Starbucks/Green Mountain Deal (PEET, SBUX, GMCR)
Thursday, March 10, 2011 - 4:43pm | 202Green Mountain Coffee Roasters (NASDAQ: GMCR) may be green with joy over its deal with Starbucks (NASDAQ: SBUX), but Peet's Coffee & Tea Inc. (NASDAQ: PEET) isn't yet “available” to comment on how it feels on the matter. That's the official word Benzinga received when it placed calls with the...
-
American Eagle Upgraded to Buy at Janney Montgomery Scott
Monday, November 29, 2010 - 9:28am | 31American Eagle (NYSE: AEO) is upgraded from Neutral to Buy at Janney Montgomery Scott. The analysts have a $20 price target on American Eagle.
-
Janney Montgomery Scott Upgrades GOV To Buy
Friday, November 12, 2010 - 7:51am | 51Analysts at Janney Montgomery Scott upgrade Government Properties Income Trust (NYSE: GOV) from "neutral" to "buy." The target price for GOV is set to $29. GOV's shares lost 0.30% to close at $26.36 yesterday. More Analyst Ratings here
-
Janney Montgomery Scott Downgrades CAVM To Neutral
Thursday, October 28, 2010 - 7:05am | 50Analysts at Janney Montgomery Scott downgrade Cavium Networks Inc (NASDAQ: CAVM) from "buy" to "neutral." The target price for CAVM is set to $30. CAVM's shares gained 6.61% to close at $32.11 yesterday. More Analyst Ratings here
-
Janney Montgomery Scott Upgrades BBT To Buy
Wednesday, October 27, 2010 - 7:31am | 50Analysts at Janney Montgomery Scott upgrade BB&T Corporation (NYSE: BBT) from "neutral" to "buy." The target price for BBT is set to $28. BBT's shares gained 0.81% to close at $22.50 yesterday. More Analyst Ratings here
-
Janney Montgomery Scott Upgrades BJ To Buy
Thursday, October 21, 2010 - 8:43am | 53Analysts at Janney Montgomery Scott upgrade BJ's Wholesale Club, Inc (NYSE: BJ) from "neutral" to "buy." The target price for BJ has been raised from $43 to $48. BJ's shares lost 1.17% to close at $41.25 yesterday. More Analyst Ratings here